California Stem Cell Companies Not Too Displeased with CIRM Rules
Sometimes directors of the $3 billion California stem cell agency worry that they are imposing too many restrictions on future grants to the biotech companies that will be the key to turning research into therapies.
Now comes a report that a number of companies "seem willing to do whatever they must to qualify for state grants." They, in fact, are not l…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.